سعر بوبروفيوتال Buprofutal SR‏ 150مجم اس ار 30 قرص 2026

Buprofutal SR 150 mg, bupropion sustained-release tablets (30 tablets) marketed in Egypt by Future Pharmaceutical Industries.

• Contraindicated in seizure disorder, current or prior bulimia or anorexia nervosa, abrupt discontinuation of alcohol, benzodiazepines, barbiturates or antiepileptics, and use with or within 14 days of MAOIs.International label, same formulation · DailyMed (US National Library of Medicine)

• Boxed warning: increased risk of suicidal thoughts and behaviours in children, adolescents and young adults taking antidepressants; monitor for clinical worsening.International label, same formulation · DailyMed (US National Library of Medicine)
• Dose-related risk of seizures; also hypertension, activation of mania, psychosis and angle-closure glaucoma.International label, same formulation · DailyMed (US National Library of Medicine)

• MAO inhibitorsContraindicated: increased risk of hypertensive reactions.DailyMed (US National Library of Medicine)
• CYP2D6 substrates (e.g. certain antidepressants, antipsychotics, beta-blockers)Bupropion inhibits CYP2D6 and may increase their levels.DailyMed (US National Library of Medicine)

• Pregnancy data have not shown a clear increased risk of major malformations; consider risks of untreated depression.International label, same formulation · DailyMed (US National Library of Medicine)

• Bupropion hydrochloride: Exact antidepressant mechanism unknown; presumed noradrenergic and/or dopaminergic; relatively weak inhibitor of neuronal norepinephrine and dopamine reuptake; no serotonin reuptake or MAO inhibition (US Wellbutrin SR label).